Who is sponsoring NCT06919211?

NCT06919211 is sponsored by Benha University.

What condition does NCT06919211 study?

NCT06919211 studies Rhegmatogenous Retinal Detachment.

Is NCT06919211 still recruiting?

NCT06919211 is currently completed. Last updated 9 April 2025.

Last reviewed 2025-04-09 · How we verify

NCT06919211

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Perfluorocarbon Liquid vs. Posterior Retinotomy During Pars-plana Vitrectomy for Rhegmatogenous Retinal Detachment

Completed NA Last updated 9 April 2025

What this trial tests

NA trial testing Perfluorocarbon Liquid vs. Posterior Retinotomy during Pars-plana Vitrectomy for The Surgical Repair of Rhegmatogenous Retinal Detachment in Rhegmatogenous Retinal Detachment in 29 participants. Completed in 30 July 2024.

Timeline

15 January 2024

Primary endpoint
30 July 2024

30 July 2024

Quick facts

Lead sponsor	Benha University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	29
Start date	15 January 2024
Primary completion	30 July 2024
Estimated completion	30 July 2024
Sites	1 location across Egypt

Drugs / interventions tested

Perfluorocarbon Liquid vs. Posterior Retinotomy during Pars-plana Vitrectomy for The Surgical Repair of Rhegmatogenous Retinal Detachment

Conditions studied

Rhegmatogenous Retinal Detachment — all drugs for Rhegmatogenous Retinal Detachment →

Sponsor

Benha University

Who can join

18 and older, any sex, with Rhegmatogenous Retinal Detachment. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Purpose To evaluate the outcomes of perfluorocarbon liquid (PFCL) versus posterior retinotomy (PR) during Pars plana vitrectomy (PPV) for Rhegmatogenous retinal detachment (RRD), focusing on anatomical success, visual acuity, intraocular pressure (IOP), and complications. Methods This is a prospective randomized controlled trial that included 58 eyes with RRD, divided into Group A (PFCL, n = 29) and Group B (PR, n = 29). Preoperative assessments included best-corrected visual acuity (BCVA), IOP, axial length, lens status, macula status, and PVR grade. Outcomes were evaluated at 1 week, 1 month, 2 months, and 3 months postoperatively. Primary outcomes included retinal reattachment rates and the number of operations; secondary outcomes included BCVA, IOP changes, complications like cataract development, retinal redetachment, epiretinal membrane (ERM) formation, and single-surgery success.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Outcomes of perfluorocarbon liquid vs. posterior retinotomy as adjuncts during pars-plana vitrectomy for the surgical repair of rhegmatogenous retinal detachment: a randomized clinical trial.
Mohamed Elsayed Saad E, Elbadry Mohammed Mohammed H, Mohamed-Aly Ibrahim M, Hassan Salama Selim O, et al · · 2025 · cited 1× · PMID 40830767 · DOI 10.1186/s12886-025-04271-w

Verify or expand the search:

Other recruiting trials for Rhegmatogenous Retinal Detachment

Currently open trials in the same condition.

NCT07283614 — Ocular Hypotony and Refractive Predictability in RRD Surgery · NA · active not recruiting
NCT07081945 — hAM for Inferior RRD · NA · recruiting
NCT06997874 — Treatment of Retinal Detachment in People Who Have Not Had Cataract Surgery With Vitrectomy vs Vitrectomy and Cataract R · Phase 3 · recruiting
NCT06826573 — Analysis of Risk Factors for High Intraocular Pressure and Retinal Detachment Recurrence After Vitrectomy with Silicone · recruiting
NCT05660447 — A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR · Phase 2, PHASE3 · active not recruiting

Other Benha University trials

Trials by the same sponsor.

NCT07526675 — Concomitant Trans-Perineal Prostate Biopsy and Ablation (Bioblation) for Prostate Cancer · NA · not yet recruiting
NCT07480031 — Determination of the Optimal Inspiratory Pressure to Decrease Incidence of Gastric Insufflation With Adequate Ventilatio · NA · not yet recruiting
NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
NCT07467356 — Anterior Iliopsoas Space Block Versus PENG Block on Ease of Positioning for Spinal Anathesia in Patients Undergoing Hip · Phase 3 · recruiting
NCT07300787 — miRNA in Pediatric Gastritis · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06919211 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Benha University
Last refreshed: 9 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06919211.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing